FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029128037> ?p ?o ?g. }

• W2029128037 endingPage "694" @default.
• W2029128037 startingPage "689" @default.
• W2029128037 abstract "Aims: We performed this retrospective study to evaluate the value of clinicopathological factors and a novel molecular marker stathmin in predicting treatment response to neoadjuvant chemotherapy (NCT) with docetaxel-containing regimens in patients with locally advanced breast cancer. Methods: Fifty-four consecutive locally advanced patients receiving docetaxel-containing NCT between January 2006 and July 2010 in Zhejiang Cancer Hospital were included. The expression levels of estrogen receptor (ER), progesterone receptor (PgR), epidermal growth factor receptor-2 (HER-2), and p53 were detected by immunohistochemistry, while expression of stathmin mRNA was measured by Quanti-Gene assay. Results: The overall clinical objective response (cOR) rate was 75.9% (41/54) in breast. A total of 34 patients (63.0%) experienced pathological OR (pOR), with pathological complete remission (pCR) rate of 20.4% (11/54) in breast and 16.7% (9/54) in both breast and axilla. In univariate analysis, there were associations of pOR in both breast and axilla with age (p=0.054), ER status (p=0.059), subtypes (p=0.062), p53 (p=0.030), and stathmin expression (three terciles) (p=0.039). Mean expression of stathmin in pOR group was 0.410, compared with that in no response group of 0.556 (p=0.051 by Student's t-test). Similarly, a lower expression of stathmin might represent a higher pCR rate (p=0.061). Moreover, the LOWESS smoothing plot showed the same trend, that is, that tumor with a lower level of stathmin expression had a higher probability of response to docetaxel-containing NCT. After multivariate adjustment, both ER and stathmin remained significant with hazard ratio of 4.58 (95% CI: 1.11–18.94, p=0.036) and 2.94 (95% CI: 1.26–6.86, p=0.012), respectively. Conclusions: In conclusion, ER and stathmin were independent predictive factors for NCT with docetaxel-containing regimens." @default.
• W2029128037 created "2016-06-24" @default.
• W2029128037 creator A5008342505 @default.
• W2029128037 creator A5040759311 @default.
• W2029128037 creator A5051776645 @default.
• W2029128037 creator A5063382829 @default.
• W2029128037 creator A5077333386 @default.
• W2029128037 creator A5081301252 @default.
• W2029128037 creator A5086664647 @default.
• W2029128037 date "2012-07-01" @default.
• W2029128037 modified "2023-09-23" @default.
• W2029128037 title "Low Expression of Stathmin in Tumor Predicts High Response to Neoadjuvant Chemotherapy with Docetaxel-Containing Regimens in Locally Advanced Breast Cancer" @default.
• W2029128037 cites W1987866132 @default.
• W2029128037 cites W2048381552 @default.
• W2029128037 cites W2052687613 @default.
• W2029128037 cites W2066882336 @default.
• W2029128037 cites W2067254583 @default.
• W2029128037 cites W2074765294 @default.
• W2029128037 cites W2087842578 @default.
• W2029128037 cites W2094838876 @default.
• W2029128037 cites W2096738399 @default.
• W2029128037 cites W2102299301 @default.
• W2029128037 cites W2107234965 @default.
• W2029128037 cites W2119416636 @default.
• W2029128037 cites W2142486051 @default.
• W2029128037 cites W2161426850 @default.
• W2029128037 cites W2163591703 @default.
• W2029128037 cites W2167033533 @default.
• W2029128037 doi "https://doi.org/10.1089/gtmb.2011.0298" @default.
• W2029128037 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3396004" @default.
• W2029128037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22480216" @default.
• W2029128037 hasPublicationYear "2012" @default.
• W2029128037 type Work @default.
• W2029128037 sameAs 2029128037 @default.
• W2029128037 citedByCount "22" @default.
• W2029128037 countsByYear W20291280372013 @default.
• W2029128037 countsByYear W20291280372014 @default.
• W2029128037 countsByYear W20291280372015 @default.
• W2029128037 countsByYear W20291280372016 @default.
• W2029128037 countsByYear W20291280372017 @default.
• W2029128037 countsByYear W20291280372020 @default.
• W2029128037 countsByYear W20291280372021 @default.
• W2029128037 countsByYear W20291280372022 @default.
• W2029128037 countsByYear W20291280372023 @default.
• W2029128037 crossrefType "journal-article" @default.
• W2029128037 hasAuthorship W2029128037A5008342505 @default.
• W2029128037 hasAuthorship W2029128037A5040759311 @default.
• W2029128037 hasAuthorship W2029128037A5051776645 @default.
• W2029128037 hasAuthorship W2029128037A5063382829 @default.
• W2029128037 hasAuthorship W2029128037A5077333386 @default.
• W2029128037 hasAuthorship W2029128037A5081301252 @default.
• W2029128037 hasAuthorship W2029128037A5086664647 @default.
• W2029128037 hasBestOaLocation W20291280372 @default.
• W2029128037 hasConcept C104317684 @default.
• W2029128037 hasConcept C121608353 @default.
• W2029128037 hasConcept C126322002 @default.
• W2029128037 hasConcept C143998085 @default.
• W2029128037 hasConcept C144301174 @default.
• W2029128037 hasConcept C204232928 @default.
• W2029128037 hasConcept C207886595 @default.
• W2029128037 hasConcept C2776608951 @default.
• W2029128037 hasConcept C2776694085 @default.
• W2029128037 hasConcept C2777292972 @default.
• W2029128037 hasConcept C2778654611 @default.
• W2029128037 hasConcept C2780140570 @default.
• W2029128037 hasConcept C2781190966 @default.
• W2029128037 hasConcept C38180746 @default.
• W2029128037 hasConcept C530470458 @default.
• W2029128037 hasConcept C55493867 @default.
• W2029128037 hasConcept C71924100 @default.
• W2029128037 hasConcept C86803240 @default.
• W2029128037 hasConceptScore W2029128037C104317684 @default.
• W2029128037 hasConceptScore W2029128037C121608353 @default.
• W2029128037 hasConceptScore W2029128037C126322002 @default.
• W2029128037 hasConceptScore W2029128037C143998085 @default.
• W2029128037 hasConceptScore W2029128037C144301174 @default.
• W2029128037 hasConceptScore W2029128037C204232928 @default.
• W2029128037 hasConceptScore W2029128037C207886595 @default.
• W2029128037 hasConceptScore W2029128037C2776608951 @default.
• W2029128037 hasConceptScore W2029128037C2776694085 @default.
• W2029128037 hasConceptScore W2029128037C2777292972 @default.
• W2029128037 hasConceptScore W2029128037C2778654611 @default.
• W2029128037 hasConceptScore W2029128037C2780140570 @default.
• W2029128037 hasConceptScore W2029128037C2781190966 @default.
• W2029128037 hasConceptScore W2029128037C38180746 @default.
• W2029128037 hasConceptScore W2029128037C530470458 @default.
• W2029128037 hasConceptScore W2029128037C55493867 @default.
• W2029128037 hasConceptScore W2029128037C71924100 @default.
• W2029128037 hasConceptScore W2029128037C86803240 @default.
• W2029128037 hasIssue "7" @default.
• W2029128037 hasLocation W20291280371 @default.
• W2029128037 hasLocation W20291280372 @default.
• W2029128037 hasLocation W20291280373 @default.
• W2029128037 hasLocation W20291280374 @default.
• W2029128037 hasOpenAccess W2029128037 @default.
• W2029128037 hasPrimaryLocation W20291280371 @default.
• W2029128037 hasRelatedWork W1964795883 @default.
• W2029128037 hasRelatedWork W1992476714 @default.

• next